Assessment of Serum 3‐Epi‐25‐Hydroxyvitamin D 3 , 25‐Hydroxyvitamin D 3 and 25‐Hydroxyvitamin D 2 in the Korean Population With UPLC – MS / MS
Journal of Clinical Laboratory Analysis · 2025-10 · 39 (19)
DOI: 10.1002/jcla.70098 ↗Abstract
ABSTRACT Background The liquid chromatography–tandem mass spectrometry method (LC–MS/MS) identified an epimeric form of 25‐hydroxyvitamin D 3 (3‐epi‐25‐OH‐D 3 ) concentrations. For the first time, the 3‐epi‐25‐OH‐D 3 was included in the Korea National Health and Nutrition Examination Survey (KNHANES) IX (from 2022 to 2024). In this study, we evaluated the results of 3‐epi‐25‐OH‐D 3 in KNHANES IX to determine its clinical status in Korea. Methods We measured 3‐epi‐OH‐D 3 , 25‐OH‐D 3 , and 25‐OH‐D 2 concentrations using an Ultra Performance (UP) LC–MS/MS, and assessed the differences in concentration ranges based on gender and age among participants in this national project. Results The concentration range of 3‐epi‐25‐OH‐D 3 among 11,744 Korean participants (5193 male and 6551 female, aged 10–80 with a median age of 53) was 0.50 (lower limit of quantification) to 15.66 ng/mL, with a mean ± SD of 1.15 ± 0.85 ng/mL. The 3‐epi‐25‐OH‐D 3 concentration was not significantly different between genders. The concentrations of 25‐OH‐D metabolites were different across age groups. There was a highly significant correlation between 3‐epi‐25‐OH‐D 3 and 25‐OH‐D 3 concentrations ( r = 0.77, R 2 = 0.5911, slope = 0.0579, p < 0.0001). The minimum and maximum of % 3‐epi‐25‐OH‐D 3 were 1.33% and 23.94%, respectively. The % 3‐epi‐25‐OH‐D 3 was highest in the highest quartile (Q4) of the total 25‐OH‐D 3 concentration ( p < 0.0001). Conclusions This is the first large‐scale study of 3‐epi‐25‐OH‐D 3 concentrations in the Korean population. Accurate measurement of 3‐epi‐25‐OH‐D 3 is necessary for the reliable results of vitamin D metabolites in KNHANES.
EUVIMED